SBI Securities’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.56K Sell
1,226
-84
-6% -$158 ﹤0.01% 2494
2025
Q4
$3.13K Hold
1,310
﹤0.01% 2218
2025
Q3
$3.73K Hold
1,310
﹤0.01% 2169
2025
Q2
$4.94K Hold
1,310
﹤0.01% 1988
2025
Q1
$5.93K Sell
1,310
-39
-3% -$206 ﹤0.01% 1829
2024
Q4
$9.54K Buy
+1,349
New +$10.7K ﹤0.01% 1666

Other funds holding HCAT

SBI Securities's HCAT Position: Q1 2026 in Review

SBI Securities reduced its Health Catalyst (HCAT) stake by 6.4% in Q1 2026, selling an estimated $158 and leaving 1,226 shares worth $1.56K. The position accounts for ﹤0.01% of the portfolio, ranked #2494.

SBI Securities first reported a position in HCAT in Q4 2024 and has held it in 6 quarters since. The position peaked at $9.54K in Q4 2024. 130 funds tracked by Wall St. Rank hold HCAT as of Q1 2026.

  • SBI Securities held 1,226 shares of Health Catalyst worth $1.56K as of Q1 2026.
  • SBI Securities sold 84 Health Catalyst shares in Q1 2026, an estimated $158.
  • Health Catalyst made up ﹤0.01% of SBI Securities's portfolio in Q1 2026, its #2494 holding.
  • SBI Securities first reported a position in Health Catalyst in Q4 2024 and has held it in 6 quarters since.
  • SBI Securities's Health Catalyst position peaked at $9.54K in Q4 2024.
  • 130 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2026.

Based on SBI Securities's 13F filing for Q1 2026, filed 28 Apr 2026.